We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
104 hedge funds and large institutions have $85.9M invested in Puma Biotechnology in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
18% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 17
2% more funds holding
Funds holding: 102 → 104 (+2)
1.87% less ownership
Funds ownership: 74.27% → 72.41% (-1.9%)
7% less capital invested
Capital invested by funds: $92.2M → $85.9M (-$6.24M)
37% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 41
63% less call options, than puts
Call options by funds: $211K | Put options by funds: $573K
Holders
104
Holders Change
+2
Holders Change %
+1.96%
% of All Funds
1.64%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
26
Reduced
41
Closed
17
Calls
$211K
Puts
$573K
Net Calls
-$362K
Net Calls Change
-$568K
Top Buyers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$5.04M |
| 2 |
ACM
Athyrium Capital Management
New York
|
+$4.64M |
| 3 |
EP
Eversept Partners
New York
|
+$793K |
| 4 |
D.E. Shaw & Co
New York
|
+$698K |
| 5 |
Millennium Management
New York
|
+$528K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$4.77M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.3M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.82M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.21M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$916K |
